- Home
- ITRG vs PSNL Comparison
ITRG vs PSNL Comparison
Compare ITRG & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ITRG | PSNL |
|---|---|---|
| Founded | 1997 | 2011 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical Specialities |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 874.5M | 729.1M |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ITRG | PSNL |
|---|---|---|
| Price | $2.88 | $6.53 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | $5.13 | ★ $12.20 |
| AVG Volume (30 Days) | ★ 3.0M | 1.5M |
| Earning Date | 05-13-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $51.39 | $15.47 |
| Revenue Next Year | N/A | $39.24 |
| P/E Ratio | $45.07 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.05 | $2.83 |
| 52 Week High | $4.87 | $11.50 |
Technical Indicators
Market Signals| Indicator | ITRG | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 38.68 |
| Support Level | $2.60 | $4.65 |
| Resistance Level | $3.24 | $6.94 |
| Average True Range (ATR) | 0.19 | 0.49 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 44.07 | 23.52 |
Price Performance
Historical ComparisonAbout ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.